According to a new study published on Oncogene, the compound thymoquinone (TQ) selectively kills prostate cancer cells in the late stages. Led by researchers at Kanazawa University, the study reported that prostate cancer cells with the SUCLA2 gene deletion can be used as therapeutic targets. Prostate cancer lacking SUCLA2 accounts for the majority of hormone therapy or metastatic resistance, so new treatment options for this disease will bring huge benefits…
Month: October 2020
STING Is Involved in the Occurrence of Motor Neurological Diseases
In a recent study, researchers from the University of Melbourne revealed the mechanism of inflammation that slows the onset of motor neuron disease (MND), thereby providing hope for people suffering from this debilitating and incurable disease. They found that by blocking immune receptor STING, they can significantly prevent inflammation in cells of MND patients, paving the way for the development of new drugs for neurodegenerative diseases such as MND….
Research Reveals Cross-species Transmission of Primate Lentivirus
Humans continue to be threatened by viral diseases such as Ebola, Zika, and Coronavirus. Such emerging/re-emerging virus outbreaks may be caused by cross-species viruses transmitted from wild animals to humans. In order to achieve cross-species transmission, the new host must be exposed to the virus in the old host. Next, the virus acquires certain mutations that may be beneficial for replication in the new host. Finally, by continuing to…